Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Microarray-based transcriptional and epigenetic profiling of matrix metalloproteinases, collagens, and related genes in cancer.

Chernov AV, Baranovskaya S, Golubkov VS, Wakeman DR, Snyder EY, Williams R, Strongin AY.

J Biol Chem. 2010 Jun 18;285(25):19647-59. doi: 10.1074/jbc.M109.088153. Epub 2010 Apr 19.

2.

Epigenetic control of the invasion-promoting MT1-MMP/MMP-2/TIMP-2 axis in cancer cells.

Chernov AV, Sounni NE, Remacle AG, Strongin AY.

J Biol Chem. 2009 May 8;284(19):12727-34. doi: 10.1074/jbc.M900273200. Epub 2009 Mar 13.

3.

Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis.

Ke XS, Qu Y, Rostad K, Li WC, Lin B, Halvorsen OJ, Haukaas SA, Jonassen I, Petersen K, Goldfinger N, Rotter V, Akslen LA, Oyan AM, Kalland KH.

PLoS One. 2009;4(3):e4687. doi: 10.1371/journal.pone.0004687. Epub 2009 Mar 5.

4.

Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.

Merdad A, Karim S, Schulten HJ, Dallol A, Buhmeida A, Al-Thubaity F, Gari MA, Chaudhary AG, Abuzenadah AM, Al-Qahtani MH.

Anticancer Res. 2014 Mar;34(3):1355-66.

PMID:
24596383
5.

Identification of coexistence of DNA methylation and H3K27me3 specifically in cancer cells as a promising target for epigenetic therapy.

Takeshima H, Wakabayashi M, Hattori N, Yamashita S, Ushijima T.

Carcinogenesis. 2015 Feb;36(2):192-201. doi: 10.1093/carcin/bgu238. Epub 2014 Dec 4.

PMID:
25477340
6.
7.
8.

MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators.

Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, Krichevsky AM.

Mol Cell Biol. 2008 Sep;28(17):5369-80. doi: 10.1128/MCB.00479-08. Epub 2008 Jun 30.

9.

Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells.

Ke XS, Qu Y, Cheng Y, Li WC, Rotter V, Øyan AM, Kalland KH.

BMC Genomics. 2010 Nov 25;11:669. doi: 10.1186/1471-2164-11-669.

10.

Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays.

Rodenhiser DI, Andrews J, Kennette W, Sadikovic B, Mendlowitz A, Tuck AB, Chambers AF.

Breast Cancer Res. 2008;10(4):R62. doi: 10.1186/bcr2121. Epub 2008 Jul 18.

11.

Defining a chromatin pattern that characterizes DNA-hypermethylated genes in colon cancer cells.

McGarvey KM, Van Neste L, Cope L, Ohm JE, Herman JG, Van Criekinge W, Schuebel KE, Baylin SB.

Cancer Res. 2008 Jul 15;68(14):5753-9. doi: 10.1158/0008-5472.CAN-08-0700.

12.

Epigenetic signatures and temporal expression of lineage-specific genes in hESCs during differentiation to hepatocytes in vitro.

Kim H, Jang MJ, Kang MJ, Han YM.

Hum Mol Genet. 2011 Feb 1;20(3):401-12. doi: 10.1093/hmg/ddq476. Epub 2010 Nov 8.

PMID:
21059703
13.

Prediction of epigenetically regulated genes in breast cancer cell lines.

Loss LA, Sadanandam A, Durinck S, Nautiyal S, Flaucher D, Carlton VE, Moorhead M, Lu Y, Gray JW, Faham M, Spellman P, Parvin B.

BMC Bioinformatics. 2010 Jun 4;11:305. doi: 10.1186/1471-2105-11-305.

14.

Emodin modulates epigenetic modifications and suppresses bladder carcinoma cell growth.

Cha TL, Chuang MJ, Tang SH, Wu ST, Sun KH, Chen TT, Sun GH, Chang SY, Yu CP, Ho JY, Liu SY, Huang SM, Yu DS.

Mol Carcinog. 2015 Mar;54(3):167-77. doi: 10.1002/mc.22084. Epub 2013 Sep 20.

PMID:
24115089
15.
16.

Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer.

Wolf I, Bose S, Desmond JC, Lin BT, Williamson EA, Karlan BY, Koeffler HP.

Breast Cancer Res Treat. 2007 Oct;105(2):139-55. Epub 2007 Feb 13.

PMID:
17295047
17.

Differentially expressed genes are marked by histone 3 lysine 9 trimethylation in human cancer cells.

Wiencke JK, Zheng S, Morrison Z, Yeh RF.

Oncogene. 2008 Apr 10;27(17):2412-21. Epub 2007 Oct 29.

PMID:
17968314
18.

Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.

Tsang DP, Wu WK, Kang W, Lee YY, Wu F, Yu Z, Xiong L, Chan AW, Tong JH, Yang W, Li MS, Lau SS, Li X, Lee SD, Yang Y, Lai PB, Yu DY, Xu G, Lo KW, Chan MT, Wang H, Lee TL, Yu J, Wong N, Yip KY, To KF, Cheng AS.

J Pathol. 2016 Apr;238(5):651-64. doi: 10.1002/path.4688.

PMID:
26800240
19.

Histone Methyltransferase hSETD1A Is a Novel Regulator of Metastasis in Breast Cancer.

Salz T, Deng C, Pampo C, Siemann D, Qiu Y, Brown K, Huang S.

Mol Cancer Res. 2015 Mar;13(3):461-9. doi: 10.1158/1541-7786.MCR-14-0389. Epub 2014 Nov 4.

20.

Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models.

Fanjul-Fernández M, Folgueras AR, Cabrera S, López-Otín C.

Biochim Biophys Acta. 2010 Jan;1803(1):3-19. doi: 10.1016/j.bbamcr.2009.07.004. Epub 2009 Jul 23. Review.

Supplemental Content

Support Center